Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Pediatr Blood Cancer. 2015 Oct 27;63(3):561–563. doi: 10.1002/pbc.25814

Figure 2. Number of admissions, pRBC and platelet transfusions related to hemorrhagic events over the course of the prophylactic regimen.

Figure 2

The patient’s medical record was reviewed over the 30 month period before her death. Prophylactic platelet infusions were not included. Admissions and transfusions clearly unrelated to bleeding were not included, e.g. admissions for infection or anemia secondary to renal failure.